A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier G, Verazza S, Giancane G, Consolaro A, Ravelli A.
Bava C, et al. Among authors: schiappapietra b.
Pediatr Rheumatol Online J. 2019 Jul 25;17(1):50. doi: 10.1186/s12969-019-0355-0.
Pediatr Rheumatol Online J. 2019.
PMID: 31345226
Free PMC article.